"Where-there-is-no-psychiatrist Integrated Personal Therapy" Among Community-Dwelling Older Adults
8 de junho de 2021 atualizado por: Shefaly Shorey, National University, Singapore
"Where-there-is-no-psychiatrist Integrated Personal Therapy" Among Community-Dwelling Older Adults: Feasibility Randomized Controlled Trial
The World Health Organization (WHO) reported that approximately 15% of adults aged 60 and above suffer from some form of mental disorder, with one of the most common neuropsychiatric disorders being depression. Similar trends are seen in Singapore where 11.4% of the older adults aged 65 and above had depressive symptoms. Another population survey conducted among elderly in Singapore showed that elderly with subsyndromal depression (SSD) were similar to or worse than elderly with Major Depressive Disorder (MDD). However being a multi-ethnic Asia society the mental conditions such as depression and anxiety are seen as taboo topics to be discussed more so to seek help or treatment for these conditions in Singapore. Additionally scarcity of trained psychiatrists and work load of these trained professionals in the acute care settings make it difficult to reach these needy older adults. Hence, it is imperative to support the needs of this group of community dwelling older adults to ensure that their emotional wellbeing, and their condition do not progress to MDD. As such, this is the first of its kind study that will evaluate the effectiveness of solution focused brief therapy delivered by the lay mindfulness practitioner and the nurses.
If the pilot intervention is found to be feasible and effective, the large scale community trial will be planned to reach to more elderly in Singapore to help them age in a dignified way. In addition, other countries that do not involve lay mindfulness practitioners and nurses to provide integrated personal therapy in the community may benefit from this study as well.
Visão geral do estudo
Status
Concluído
Intervenção / Tratamento
Tipo de estudo
Intervencional
Inscrição (Real)
21
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
-
Singapore, Cingapura, 117597
- National University of Singapore
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
60 anos a 95 anos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- Community-dwelling older adults aged between 60-95 years old
- Able to understand and speak either English and/or Mandarin
- Able to attend at least 80% (five out of seven sessions) of the intervention sessions
- Have subsyndromal depression (obtained a score between one and five on the Geriatric Depression Scale) and/or subsyndromal anxiety (obtained a score between three and 10 on the Geriatric Anxiety Scale)
Exclusion Criteria:
- Older adults aged between 60-95 years old without subsyndromal depression and/or subsyndromal anxiety
- Older adults aged between 60-95 years old who could not understand or speak either English and/or Mandarin.
- Older adults aged between 60-95 years old who were unable to attend at least 80% (five out of seven sessions) of the intervention sessions.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Ao controle
Sem intervenção
|
|
|
Experimental: Where-there-is-no-psychiatrist Integrated Personal Therapy (WIPT)
Solution-focused brief therapy (SFBT) involving psychoeducation and structured life review therapy, as well as mindfulness-based training
|
The WIPT include weekly face-to-face group sessions including mindfulness-based training and solution focused brief therapy (SFBT) involving psychoeducation and structured life review therapy catered to the personal needs of the participants.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Symptoms of depression
Prazo: Prior to start of intervention
|
Measured using Geriatric Depression Scale.
15-item scale where participants select either "Yes" or "No" in response to 15 statements.
The maximum score that could be obtained was 15 points; a high score on the scale indicates severe depressive symptoms.
|
Prior to start of intervention
|
|
Symptoms of depression
Prazo: 3 months post-recruitment
|
Measured using Geriatric Depression Scale.
15-item scale where participants select either "Yes" or "No" in response to 15 statements.
The maximum score that could be obtained was 15 points; a high score on the scale indicates severe depressive symptoms.
|
3 months post-recruitment
|
|
Symptoms of depression
Prazo: 6 months post-recruitment
|
Measured using Geriatric Depression Scale.
15-item scale where participants select either "Yes" or "No" in response to 15 statements.
The maximum score that could be obtained was 15 points; a high score on the scale indicates severe depressive symptoms.
|
6 months post-recruitment
|
|
Symptoms of anxiety
Prazo: Prior to start of intervention
|
Measured using Geriatric Anxiety Inventory.
20-item scale where participants select either "Agree" or "Disagree" to assess the anxiety symptoms in older adults.
The maximum score that could be obtained was 20 points; a high score indicates more anxiety symptoms.
|
Prior to start of intervention
|
|
Symptoms of anxiety
Prazo: 3 months post-recruitment
|
Measured using Geriatric Anxiety Inventory.
20-item scale where participants select either "Agree" or "Disagree" to assess the anxiety symptoms in older adults.
The maximum score that could be obtained was 20 points; a high score indicates more anxiety symptoms.
|
3 months post-recruitment
|
|
Symptoms of anxiety
Prazo: 6 months post-recruitment
|
Measured using Geriatric Anxiety Inventory.
20-item scale where participants select either "Agree" or "Disagree" to assess the anxiety symptoms in older adults.
The maximum score that could be obtained was 20 points; a high score indicates more anxiety symptoms.
|
6 months post-recruitment
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Life satisfaction
Prazo: Prior to start of intervention
|
Measured using Satisfaction with Life Scale.
5-item scale that included a 7-point Likert scale (1 = "Strongly Disagree"; 7 = "Strongly Agree").
The maximum score that could be obtained was 35 points; a high score indicates high level of satisfaction with life.
|
Prior to start of intervention
|
|
Life satisfaction
Prazo: 3 months post-recruitment
|
Measured using Satisfaction with Life Scale.
5-item scale that included a 7-point Likert scale (1 = "Strongly Disagree"; 7 = "Strongly Agree").
The maximum score that could be obtained was 35 points; a high score indicates high level of satisfaction with life.
|
3 months post-recruitment
|
|
Life satisfaction
Prazo: 6 months post-recruitment
|
Measured using Satisfaction with Life Scale.
5-item scale that included a 7-point Likert scale (1 = "Strongly Disagree"; 7 = "Strongly Agree").
The maximum score that could be obtained was 35 points; a high score indicates high level of satisfaction with life.
|
6 months post-recruitment
|
|
Social connectedness in terms of friendship
Prazo: Prior to start of intervention
|
Measured using Friendship Scale.
6-item where participants had to select an answer out of the five options (1 = "Not at All"; 5 = "Almost Always").
The maximum score that could be obtained was 30 points; a high score indicates high level of social connectedness.
|
Prior to start of intervention
|
|
Social connectedness in terms of friendship
Prazo: 3 months post-recruitment
|
Measured using Friendship Scale.
6-item where participants had to select an answer out of the five options (1 = "Not at All"; 5 = "Almost Always").
The maximum score that could be obtained was 30 points; a high score indicates high level of social connectedness.
|
3 months post-recruitment
|
|
Social connectedness in terms of friendship
Prazo: 6 months post-recruitment
|
Measured using Friendship Scale.
6-item where participants had to select an answer out of the five options (1 = "Not at All"; 5 = "Almost Always").
The maximum score that could be obtained was 30 points; a high score indicates high level of social connectedness.
|
6 months post-recruitment
|
|
Quality of life
Prazo: Prior to start of intervention
|
Measured using World Health Organization Quality of Life-Older Adults module.
13-item scale where participants had to select an answer based on a 5-point rating scale (1 = "Not at All"; 5 = "Very Satisfied").
The maximum score was 65 points, and a high score indicates high quality of life.
|
Prior to start of intervention
|
|
Quality of life
Prazo: 3 months post-recruitment
|
Measured using World Health Organization Quality of Life-Older Adults module.
13-item scale where participants had to select an answer based on a 5-point rating scale (1 = "Not at All"; 5 = "Very Satisfied").
The maximum score was 65 points, and a high score indicates high quality of life.
|
3 months post-recruitment
|
|
Quality of life
Prazo: 6 months post-recruitment
|
Measured using World Health Organization Quality of Life-Older Adults module.
13-item scale where participants had to select an answer based on a 5-point rating scale (1 = "Not at All"; 5 = "Very Satisfied").
The maximum score was 65 points, and a high score indicates high quality of life.
|
6 months post-recruitment
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Cortisol in ng/ml
Prazo: Prior to start of intervention
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
Prior to start of intervention
|
|
Cortisol in ng/ml
Prazo: 6 months post-recruitment
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
6 months post-recruitment
|
|
Annexin-A1 in ng/ml
Prazo: Prior to start of intervention
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
Prior to start of intervention
|
|
Annexin-A1 in ng/ml
Prazo: 6 months post-recruitment
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
6 months post-recruitment
|
|
Interleukin-1-beta in pg/ml
Prazo: Prior to start of intervention
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
Prior to start of intervention
|
|
Interleukin-1-beta in pg/ml
Prazo: 6 months post-recruitment
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
6 months post-recruitment
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
1 de setembro de 2019
Conclusão Primária (Real)
31 de janeiro de 2020
Conclusão do estudo (Real)
31 de março de 2020
Datas de inscrição no estudo
Enviado pela primeira vez
1 de junho de 2021
Enviado pela primeira vez que atendeu aos critérios de CQ
8 de junho de 2021
Primeira postagem (Real)
15 de junho de 2021
Atualizações de registro de estudo
Última Atualização Postada (Real)
15 de junho de 2021
Última atualização enviada que atendeu aos critérios de controle de qualidade
8 de junho de 2021
Última verificação
1 de junho de 2021
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- A17-2003-B
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Não
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .